ARCHIVES

Amgen, Genentech Drug Giveaway Programs Likely to Meet Resistance From Doctors, Potential Problems at CMS.

This article is from The Cancer Letter archive.

Vol. 32 No. 36 | October 13, 2006

Download PDF Visit The Full Archive

Related Articles

New Abiraterone Acetate Results Show Greater Benefit Than Before

June 24, 2011

Subcommittee chairman Critical Of DCR For Lack Of “Game Plan”

October 28, 1977

DRCCA Board Again Approves Breast Cancer Dietary Study

May 13, 1983

Recommendations For Adjuvant Therapy In Breast Cancer

September 20, 1985

Large Studies Show Promising Results For Targeted Therapies Alimta, Tarceva

June 26, 2009

FDA Grants Six-Month Priority Review To Nolvadex For DCIS Adjuvant Treatment.

March 31, 2000